S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Is Buying an Aged Corporation a Good Idea?
Is This The End of Capitalism? (Ad)
MarketBeat Week in Review – 1/23- 1/27
Lots of sound and fury on US debt, but not a crisis — yet
The Next Big Crisis Is Here (Ad)
Italy's premier visits Libya for talks on energy, migration
Italy, Libya sign $8B gas deal as PM Meloni visits Tripoli
The Next Big Crisis Is Here (Ad)
Japan firm opens whale meat vending machines to push sales
Online system to seek asylum in US is quickly overwhelmed
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Is Buying an Aged Corporation a Good Idea?
Is This The End of Capitalism? (Ad)
MarketBeat Week in Review – 1/23- 1/27
Lots of sound and fury on US debt, but not a crisis — yet
The Next Big Crisis Is Here (Ad)
Italy's premier visits Libya for talks on energy, migration
Italy, Libya sign $8B gas deal as PM Meloni visits Tripoli
The Next Big Crisis Is Here (Ad)
Japan firm opens whale meat vending machines to push sales
Online system to seek asylum in US is quickly overwhelmed
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Is Buying an Aged Corporation a Good Idea?
Is This The End of Capitalism? (Ad)
MarketBeat Week in Review – 1/23- 1/27
Lots of sound and fury on US debt, but not a crisis — yet
The Next Big Crisis Is Here (Ad)
Italy's premier visits Libya for talks on energy, migration
Italy, Libya sign $8B gas deal as PM Meloni visits Tripoli
The Next Big Crisis Is Here (Ad)
Japan firm opens whale meat vending machines to push sales
Online system to seek asylum in US is quickly overwhelmed
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Is Buying an Aged Corporation a Good Idea?
Is This The End of Capitalism? (Ad)
MarketBeat Week in Review – 1/23- 1/27
Lots of sound and fury on US debt, but not a crisis — yet
The Next Big Crisis Is Here (Ad)
Italy's premier visits Libya for talks on energy, migration
Italy, Libya sign $8B gas deal as PM Meloni visits Tripoli
The Next Big Crisis Is Here (Ad)
Japan firm opens whale meat vending machines to push sales
Online system to seek asylum in US is quickly overwhelmed
NASDAQ:VIR

Vir Biotechnology - VIR News Today

$30.85
+0.86 (+2.87%)
(As of 01/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$29.91
$31.55
50-Day Range
$24.80
$30.85
52-Week Range
$18.05
$35.48
Volume
767,934 shs
Average Volume
697,478 shs
Market Capitalization
$4.11 billion
P/E Ratio
3.63
Dividend Yield
N/A
Price Target
$52.50
Get Vir Biotechnology News Delivered to You Automatically

Sign up to receive the latest news and ratings for VIR and its competitors with MarketBeat's FREE daily newsletter.



VIR Media Mentions By Week

VIR Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

VIR
News Sentiment

0.41

0.71

Average
Medical
News Sentiment

VIR News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

VIR Articles
This Week

25

4

VIR Articles
Average Week

SourceHeadline
marketbeat.com logoRoyce & Associates LP Invests $546,000 in Vir Biotechnology, Inc. (NASDAQ:VIR)
marketbeat.com - January 27 at 5:35 AM
marketbeat.com logoBank Julius Baer & Co. Ltd Zurich Sells 65,007 Shares of Vir Biotechnology, Inc. (NASDAQ:VIR)
marketbeat.com - January 26 at 7:14 AM
marketbeat.com logoComerica Bank Sells 5,405 Shares of Vir Biotechnology, Inc. (NASDAQ:VIR)
marketbeat.com - January 24 at 4:29 AM
marketbeat.com logoLos Angeles Capital Management LLC Boosts Stock Position in Vir Biotechnology, Inc. (NASDAQ:VIR)
marketbeat.com - January 23 at 5:52 AM
MarketBeat logoVir Biotechnology (NASDAQ:VIR) Upgraded to "Equal Weight" at Morgan Stanley
americanbankingnews.com - January 28 at 6:28 AM
MarketBeat logoVir Biotechnology (NASDAQ:VIR) Price Target Cut to $43.00 by Analysts at SVB Leerink
americanbankingnews.com - January 28 at 6:28 AM
MarketBeat logoEndurance (Cayman) Ltd Svf Sells 36,512 Shares of Vir Biotechnology, Inc. (NASDAQ:VIR) Stock
americanbankingnews.com - January 28 at 5:10 AM
MarketBeat logoInsider Selling: Vir Biotechnology, Inc. (NASDAQ:VIR) Insider Sells 30,000 Shares of Stock
americanbankingnews.com - January 28 at 5:10 AM
markets.businessinsider.com logoSVB Securities Keeps Their Buy Rating on Vir Biotechnology (VIR)
markets.businessinsider.com - January 27 at 8:16 AM
markets.businessinsider.com logoAnalyst Expectations for Vir Biotechnology's Future
markets.businessinsider.com - January 27 at 8:16 AM
bizjournals.com logo'You have to have the goods': Retiring Vir CEO George Scangos looks back on building great companies
bizjournals.com - January 26 at 9:20 AM
finance.yahoo.com logo'You have to have the goods': Retiring Vir CEO George Scangos on building great companies
finance.yahoo.com - January 25 at 6:52 PM
bizjournals.com logoWednesday Digest: S.F. sets a massive housing goal; Biotech names a new CEO
bizjournals.com - January 25 at 1:23 PM
bloomberg.com logoCovid Drugmaker Vir Replaces CEO With Bayer Executive as It Searches for Next Hit
bloomberg.com - January 25 at 1:23 PM
finance.yahoo.com logoVir Biotechnology Announces Retirement of CEO George Scangos, Ph.D.; Appoints Marianne De Backer, MSc, Ph.D., MBA, as Successor
finance.yahoo.com - January 25 at 8:51 AM
MarketBeat logoEndurance (Cayman) Ltd Svf Sells 69,839 Shares of Vir Biotechnology, Inc. (NASDAQ:VIR) Stock
americanbankingnews.com - January 25 at 4:32 AM
finance.yahoo.com logoVir Biotechnology, Inc. (VIR) Moves to Strong Buy: Rationale Behind the Upgrade
finance.yahoo.com - January 24 at 2:39 PM
msn.com logo2 Stocks That Could Turn $100 Into $1,000 by 2028
msn.com - January 22 at 8:07 AM
finance.yahoo.com logo10 Best Healthcare Stocks For the Long Term
finance.yahoo.com - January 21 at 6:11 PM
finance.yahoo.com logoAre Robust Financials Driving The Recent Rally In Vir Biotechnology, Inc.'s (NASDAQ:VIR) Stock?
finance.yahoo.com - January 21 at 8:10 AM
finance.yahoo.com logoIs Vir Biotechnology (VIR) Outperforming Other Medical Stocks This Year?
finance.yahoo.com - January 20 at 1:48 PM
MarketBeat logoVir Biotechnology, Inc. (NASDAQ:VIR) Major Shareholder Endurance (Cayman) Ltd Svf Sells 88,372 Shares of Stock
americanbankingnews.com - January 20 at 6:16 AM
seekingalpha.com logoVir Biotechnology: High Potential Returns With High Volatility Risks
seekingalpha.com - January 19 at 7:47 AM
MarketBeat logoVir Biotechnology, Inc. (NASDAQ:VIR) Major Shareholder Endurance (Cayman) Ltd Svf Sells 94,199 Shares
americanbankingnews.com - January 19 at 4:12 AM
businessinsider.com logoFormer CEO says Biogen 'shot themselves in the foot' by deciding to charge $56,000 for its controversial Alzheimer's drug
businessinsider.com - January 18 at 8:37 AM
MarketBeat logoAnalysts Set Vir Biotechnology, Inc. (NASDAQ:VIR) Price Target at $52.50
americanbankingnews.com - January 18 at 4:02 AM
finance.yahoo.com logoVir Biotechnology to Highlight Anticipated 2023 Catalysts and Long-Term Growth Strategy at 41st Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 3 at 4:59 PM
finance.yahoo.com logoAre Investors Undervaluing Vir Biotechnology, Inc. (NASDAQ:VIR) By 32%?
finance.yahoo.com - December 31 at 12:13 PM
msn.com logoDrug companies set sights on new COVID medicines to boost depleted arsenal
msn.com - December 27 at 8:26 PM
msn.com logoDrug companies set sights on new COVID medicines to boost depleted arsenal
msn.com - December 27 at 8:26 PM
finance.yahoo.com logoVir Biotechnology: A 'Magic Formula' Top Performer
finance.yahoo.com - December 22 at 6:12 PM
finance.yahoo.com logoVir Biotechnology Achieves Target Enrollment for Groundbreaking Phase 2 PENINSULA Trial Evaluating VIR-2482 for Prevention of Seasonal Influenza A
finance.yahoo.com - December 21 at 9:18 AM
seekingalpha.com logoVir Biotechnology: Collaborative Approach To Taking On Serious Diseases
seekingalpha.com - December 17 at 10:22 AM
finance.yahoo.com logoWith 49% stake, Vir Biotechnology, Inc. (NASDAQ:VIR) seems to have captured institutional investors' interest
finance.yahoo.com - December 6 at 8:54 AM
finance.yahoo.com logo2 Fast-Growing Healthcare Stocks to Buy and Hold
finance.yahoo.com - December 2 at 9:12 AM
markets.businessinsider.com logoBioNTech, Vertex Pharmaceuticals And Other Big Biotechnology Stocks From Benzinga's Most Accurate Analysts
markets.businessinsider.com - December 2 at 7:08 AM
finance.yahoo.com logoWall Street Analysts Believe Vir Biotechnology, Inc. (VIR) Could Rally 71%: Here's is How to Trade
finance.yahoo.com - November 24 at 2:13 PM
finance.yahoo.com logoShould Value Investors Buy Vir Biotechnology (VIR) Stock?
finance.yahoo.com - November 22 at 4:30 PM
msn.com logoAfter Bill Gates Dumps Billions In Berkshire To Buy Microsoft, His Quiet Biotech Portfolio Has Made A New Trade
msn.com - November 18 at 4:44 PM
bizjournals.com logo99 Bay Area companies named in Deloitte 'fast 500' list, including its No. 1
bizjournals.com - November 18 at 9:11 AM
finance.yahoo.com logo99 Bay Area companies named in Deloitte's Technology Fast 500 list, including its No. 1
finance.yahoo.com - November 18 at 9:11 AM
finance.yahoo.com logoVir Biotechnology Ranked the Fastest-Growing Company in North America on the 2022 Deloitte Technology Fast 500™
finance.yahoo.com - November 16 at 4:06 PM
finance.yahoo.com logoVir Biotechnology Ranked the Fastest-Growing Company in North America on the 2022 Deloitte Technology Fast 500™
finance.yahoo.com - November 16 at 4:06 PM
benzinga.com logoMoore Kuehn, PLLC Encourages Investors of Vir Biotechnology, Inc. to Contact Law Firm
benzinga.com - November 10 at 5:23 PM
finance.yahoo.com logoVir Biotechnology Third Quarter 2022 Earnings: Beats Expectations
finance.yahoo.com - November 9 at 10:33 AM
finance.yahoo.com logoWall Street Analysts Predict a 107% Upside in Vir Biotechnology, Inc. (VIR): Here's What You Should Know
finance.yahoo.com - November 8 at 2:59 PM
msn.com logoWhy MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday
msn.com - November 7 at 4:46 AM
finance.yahoo.com logoVir Biotechnology Presents New Data Evaluating the Potential for VIR-2218 and VIR-3434 to Achieve a Functional Cure for Chronic Hepatitis B Virus (HBV) Infection
finance.yahoo.com - November 6 at 5:18 PM
finance.yahoo.com logoAnalyst Forecasts For Vir Biotechnology, Inc. (NASDAQ:VIR) Are Surging Higher
finance.yahoo.com - November 5 at 1:41 PM
finance.yahoo.com logoTop Biotech Stocks for Q4 2022
finance.yahoo.com - November 4 at 7:04 PM
finance.yahoo.com logoWhy Vir Biotechnology Jumped Nearly 19% Today
finance.yahoo.com - November 4 at 4:48 PM
markets.businessinsider.com logoNeedham Reaffirms Their Buy Rating on Vir Biotechnology (VIR)
markets.businessinsider.com - November 4 at 2:02 PM
markets.businessinsider.com logoWhat 5 Analyst Ratings Have To Say About Vir Biotechnology
markets.businessinsider.com - November 4 at 2:02 PM
finance.yahoo.com logoVir Biotechnology, Inc. (VIR) Q3 Earnings and Revenues Surpass Estimates
finance.yahoo.com - November 4 at 2:02 PM
Get Vir Biotechnology News Delivered to You Automatically

Sign up to receive the latest news and ratings for VIR and its competitors with MarketBeat's FREE daily newsletter.

This page (NASDAQ:VIR) was last updated on 1/28/2023 by MarketBeat.com Staff